Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04419909 · ClinicalTrials.gov registry record · Phase 1
Retreatment With CTL019/CTL119
A Phase 1 study, sponsored by University of Pennsylvania.
- Not yet
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT04419909: Clinical Trial Phase 1 study, sponsored by University of Pennsylvania.
NCT04419909 is a Phase 1 study that has not yet begun recruiting, run by University of Pennsylvania. The registered enrollment target is 12 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04419909, a Phase 1 study, has not yet begun recruiting, sponsored by University of Pennsylvania.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This research study is designed to evaluate the effects of retreatment with CTL019/CTL119 in patients with late relapse of B-cell lymphomas.
Interventions
- DRUG CD19 redirected autologous T cells (CTL019 or CTL119 cells)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-05 |
| Est. Completion | 2028-07 |
| Phase | Phase 1 |
What is known before NCT04419909 opens enrollment
NCT04419909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which CD19 redirected autologous T cells (CTL019 or CTL119 cells) is the first listed.
NCT04419909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04419909 about?
NCT04419909 is a clinical study titled "Retreatment With CTL019/CTL119". This research study is designed to evaluate the effects of retreatment with CTL019/CTL119 in patients with late relapse of B-cell lymphomas.
What is the current status of trial NCT04419909?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2026-05. Estimated completion is 2028-07.
What interventions are being tested in trial NCT04419909?
The interventions under investigation include: CD19 redirected autologous T cells (CTL019 or CTL119 cells) (DRUG).
Who is sponsoring clinical trial NCT04419909?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04419909's enrollment target sits among peer trials
12 1852nd of 2000 higher than 90 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia